Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy ; volume:15 ; number:1 ; day:4 ; month:5 ; year:2020 ; pages:1-13 ; date:12.2020
Radiation oncology ; 15, Heft 1 (4.5.2020), 1-13, 12.2020
- Urheber
-
Mazzola, Rosario
Jereczek-Fossa, Barbara Alicja
Franceschini, Davide
Tubin, Slavisa
Filippi, Andrea Riccardo
Tolia, Maria
Lancia, Andrea
Minniti, Giuseppe
Corradini, Stefanie
Arcangeli, Stefano
Scorsetti, Marta
Alongi, Filippo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13014-020-01544-0
- URN
-
urn:nbn:de:101:1-2020071213552261541034
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mazzola, Rosario
- Jereczek-Fossa, Barbara Alicja
- Franceschini, Davide
- Tubin, Slavisa
- Filippi, Andrea Riccardo
- Tolia, Maria
- Lancia, Andrea
- Minniti, Giuseppe
- Corradini, Stefanie
- Arcangeli, Stefano
- Scorsetti, Marta
- Alongi, Filippo
- SpringerLink (Online service)
Ähnliche Objekte (12)
BCMA-targeted immunotherapy for multiple myeloma
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Oligomeric tau-targeted immunotherapy in Tg4510 mice
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Systemic lupus erythematosus: pathogenesis and targeted therapy
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
Novel targeted therapies and immunotherapy for advanced thyroid cancers
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Immunological effect of local ablation combined with immunotherapy on solid malignancies
BCMA-targeted immunotherapy for multiple myeloma
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Oligomeric tau-targeted immunotherapy in Tg4510 mice
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Systemic lupus erythematosus: pathogenesis and targeted therapy
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
Novel targeted therapies and immunotherapy for advanced thyroid cancers
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
Immunological effect of local ablation combined with immunotherapy on solid malignancies
BCMA-targeted immunotherapy for multiple myeloma
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Targeted therapy, immunotherapy, and chemotherapy for chordoma
Oligomeric tau-targeted immunotherapy in Tg4510 mice
Targeted Therapy and Immunotherapy for Melanoma in Japan
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Targeted Cancer Immunotherapy: Nanoformulation Engineering and Clinical Translation
Systemic lupus erythematosus: pathogenesis and targeted therapy
SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy
Novel targeted therapies and immunotherapy for advanced thyroid cancers
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia